Anavex Life Sciences (AVXL) - Shares outstanding

Number of shares outstanding as of May 2026 : 89,029,458

According to Anavex Life Sciences 's latest financial reports and stock price the company's current number of shares outstanding is 89,029,458. At the end of 2025 the company had 89,029,458 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Anavex Life Sciences from 2015 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	89.02 M	4.98%
2024	84.8 M	3.32%
2023	82.07 M	5.26%
2022	77.97 M	2.6%
2021	75.99 M	18.2%
2020	64.29 M	17.38%
2019	54.77 M	18.23%
2018	46.32 M	5.57%
2017	43.88 M	14.3%
2016	38.39 M	13.02%
2015	33.97 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Ligand Pharmaceuticals LGND	19,726,000	-77.84%	🇺🇸 USA
Corcept Therapeutics CORT	103,695,000	16.47%	🇺🇸 USA
Palatin Technologies PTN	971,650	-98.91%	🇺🇸 USA
BioCryst Pharmaceuticals BCRX	209,893,000	135.76%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Anavex Life Sciences (AVXL)

Number of shares outstanding as of May 2026 : 89,029,458